Last updated on March 2019

Open Label Safety Study in Acute Treatment of Migraine


Brief description of study

The purpose of this study is to evaluate safety and tolerability of BHV3000 (rimegepant).

Clinical Study Identifier: NCT03266588

Contact Investigators or Research Sites near you

Start Over

Radiant Research, Inc.

Jamaica, NY United States
2.87miles

Fieve Clinical Research

New York, NY United States
7.07miles

Montefiore Heachache Center

Bronx, NY United States
8.55miles

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.